期刊
TOXIN REVIEWS
卷 41, 期 3, 页码 1018-1029出版社
TAYLOR & FRANCIS INC
DOI: 10.1080/15569543.2021.1942063
关键词
Snakebite; antivenoms; IgY; phage display technology; monoclonal IgY
类别
资金
- DBT-BIRAC [BT/AIR0342/PACE-13/17]
- [BIRAC-BIG-CCAMP0841/BIG-14/19]
Research has shown that chicken egg yolk (IgY) antibodies have the potential to be used as an alternative to mammalian antibodies for treating snakebites. There is currently a debate surrounding the use of IgY in snakebite therapy.
Snakebite and its envenomation are a significant health and economic burden worldwide. Animal (horse/sheep)-based immunoglobulins derived from hyperimmune animal serum or plasma is the current treatment modality for snake envenomation. Chicken egg yolk (IgY) antibodies in the recent past have become one of the promising tools for research as an alternative to these mammalian antibodies. IgY have been a reason of debate from past three decades for its applications in snakebite therapy. The ease of producing pure, specific, and high affinity antivenoms have shown that IgY antivenoms can be used for treating snake bites.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据